Aaron Mitchell (@aaronwmitchell) header
Aaron Mitchell (@aaronwmitchell) profile picture

Bringing business impact to the science of R&D as a @ZSAssociates principal. Alum of @BerkeleyHaas & @WestPoint_USMA. Tweets are my own.

San Francisco, CA
Joined June 2012
Photo by Aaron Mitchell (@aaronwmitchell)Photo by Aaron Mitchell (@aaronwmitchell)Photo by Aaron Mitchell (@aaronwmitchell)Photo by Aaron Mitchell (@aaronwmitchell)Photo by Aaron Mitchell (@aaronwmitchell)Photo by Aaron Mitchell (@aaronwmitchell)Photo by Aaron Mitchell (@aaronwmitchell)Photo by Aaron Mitchell (@aaronwmitchell)Photo by Aaron Mitchell (@aaronwmitchell)Photo by Aaron Mitchell (@aaronwmitchell)
This biotech milestone is one to celebrate. Regulators in the U.K. approved the first drug created with CRISPR gene editing technology, Casgevy, for the treatment of sickle cell disease and beta thalassemia #CRISPR #biotechnology #innovation statnews.com/2023/11/16/cris… via @statnews
2
42
In ZS’s first-ever HEOR report, Barry Farrimond and George Agathangelou discuss the most pressing challenges that HEOR should be taking on: equitable pricing, emerging markets, demographic changes and health system capacity. #HEOR #pharma zs.com/insights/technology-i…
32
ZS’s @MariaWhitman and Bill Coyle are joined by clinical psychologist Mandi White-Ajmani, PhD, for a thoughtful, candid podcast episode about the short- and long-term impact of GLP-1s on patient outcomes, including mental health. #GLP1 #obesity zs.com/insights/obesity-a-pa…
1
45
Great conversation on a HIMSS podcast featuring my colleague, Arnab Roy and guests from Takeda to discuss the role digital endpoints and biomarkers can play in decreasing trial burden and advancing rare disease research. zs.com/insights/digital-biom…
15
If you’re attending the CNS Summit this week, don’t miss my colleague, April Lewis, who will be discussing opportunities for sponsors to collect and use patient insights in the delivery of clinical trials. #CNSSummit23 #patientexperience #clinicaltrials
9
ZS research tells us that antibody drug conjugates (ADCs) are going to have a dramatic impact on the standard of care in oncology. Companies with ADC platforms should consider partnerships or acquisitions now. #oncology #pharma #ADCs pharmaphorum.com/oncology/an…
15
I’m thrilled that ZS was recently recognized as a Leader by IDC MarketScape in its first ever assessment of real-world evidence (RWE) and real-world data (RWD) consulting services and vendors. #RWE #RWD #lifesciences zs.com/insights/idc-marketsc…
5
Sign up for ZS Discovery’s on-demand webinar about data management challenges and best practices for using multiomics to develop safer and more effective drugs. Register here: bit.ly/3rkxxf7 #omics #lifesciences #datamanagement zs.com/insights/optimize-you…
8
It was great to see everyone at #BioTechX this week where I talked about the 5 pillars of pharma R&D transformation to improve the ROI on R&D investment and deliver better innovations to more patient faster.
12
A new ZS white paper shares strategies for using collaborative intelligence to drive innovation in clinical development. #AI #machinelearning #pharmahttps zs.com/insights/zs-white-pap…
6
I suspect we’ll start to see more partnerships like this one between BMS and Viz.ai that helps cardiologists identify candidates for new treatments. #pharma #healthtech statnews.com/2023/08/15/bms-… via @statnews
10